Antiretroviral therapy and early mortality in South Africa.
暂无分享,去创建一个
Karen Cohen | Peter Bock | A. Boulle | K. Cohen | M. Osler | K. Hilderbrand | V. Zweigenthal | Katherine Hilderbrand | Andrew Boulle | E. Mothibi | Meg Osler | Liezl Channing | Eula Mothibi | Virginia Zweigenthal | Neviline Slingers | Keith Cloete | Fareed Abdullah | P. Bock | K. Cloete | F. Abdullah | Liezl Channing | Neviline Slingers
[1] Reed M. Gardner,et al. Viewpoint Paper: Viewpoint: A Pragmatic Approach to Constructing a Minimum Data Set for Care of Patients with HIV in Developing Countries , 2006, J. Am. Medical Informatics Assoc..
[2] L. Myer,et al. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design , 2005, AIDS.
[3] L. Myer,et al. Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa. , 2006, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[4] A. Boulle,et al. Anticipating future challenges to ART provision in South Africa : reflections on the Khayelitsha ART programme , 2006 .
[5] O. Laeyendecker,et al. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda , 2007, AIDS.
[6] E. Schouten,et al. True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. , 2007, Bulletin of the World Health Organization.
[7] D. Mcintyre,et al. The cost-effectiveness of Antiretroviral Treatment in Khayelitsha, South Africa – a primary data analysis , 2006, Cost effectiveness and resource allocation : C/E.
[8] J. Sterne,et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries , 2006, The Lancet.
[9] A. Harries,et al. Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi model. , 2004, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[10] Paul Milligan,et al. Bulletin of the World Health Organization , 2017 .
[11] Sydney Rosen,et al. Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review , 2007, PLoS medicine.
[12] Lesley E Scott,et al. CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration. , 2002, Cytometry.
[13] G. Maartens,et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa , 2004, AIDS.
[14] B. Chi,et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. , 2006, JAMA.
[15] A. Boulle,et al. A Review of Antiretroviral Costing Models in South Africa , 2003 .
[16] Ken Wong,et al. Issues and challenges , 1993 .
[17] J. Myers,et al. Public health lessons from a pilot programme to reduce mother-to-child transmission of HIV-1 in Khayelitsha. , 2001, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[18] M. Wildner. Lost to follow-up. , 1995, The Journal of bone and joint surgery. British volume.
[19] A. Boulle,et al. Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa. , 2005, Bulletin of the World Health Organization.
[20] A. Boulle,et al. Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa , 2004, AIDS.
[21] S. Lawn,et al. Conservation of First-Line Antiretroviral Treatment Regimen where Therapeutic Options are Limited , 2007, Antiviral therapy.